Wednesday, December 6, 2023
July 19 - 22, 2015; Vancouver, British Columbia, Canada
IAS
Self-Testing Takes Off in Men When Women Are Given HIV Kits
IAS
'Sensational' Hep C Response Rates in HIV Coinfection Trial
IAS
Large Study Backs Switch to Next-Gen Tenofovir for HIV
IAS
Cash Incentives Fail to Prevent HIV in Impoverished Girls
IAS
No Benefit of Empiric Tuberculosis Treatment in Advanced HIV
IAS
Same-Day Diagnosis, Treatment a Hit Among HIV Patients
IAS
HIV Cure Advancing From Isolated Cases to Clinical Trials
IAS
HIV Pre-exposure Prophylaxis Popular in High-Risk Patients
IAS
Nondaily Treatment an Option for Those at High Risk for HIV
IAS
Single-Pill Hep C Treatment Effective in Patients With HIV
IAS
Early Antiretrovirals Protect HIV Serodiscordant Couples
IAS
Opioid Substitution Saves Lives of HIV-Positive Drug Users
IAS
START Antiretrovirals Early, 35-Country Trial Validates
IAS
HIV Treatment as Prevention Saves Money Over Long Term
IAS
Early Treatment Trial to Headline AIDS Conference
Medscape HIV/AIDS© WebMD, LLC